Photo from Graham Collins/X
Jun 21, 2024, 05:59
Results of ECHO study EHA
Graham Collins, Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared on X/Twitter:
“Wang – Echo study EHA2024
– BR v Acala-BR in 1L Mantle,65 years and older
– randomised, double blind, placebo-controlled
– Clear PFS benefit: 27% reduction PD / death
– Trend to OS but not stat sig even when COVID deaths removed
– low cardiac events, slightly more infections.
New SOC?”
Source: Graham Collins/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19